Picture of AFC-HD AMS Life Science logo

2927 — AFC-HD AMS Life Science News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesConservativeSmall CapNeutral

Table: AFC-HD Ams Life Science -2021/22 group results

Oct 14 (Reuters)- 
          AFC-HD Ams Life Science Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Aug 31, 2022    Aug 31, 2021   Aug 31, 2023     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             23.00           22.37          24.74        12.19    
                                                (+7.6 pct)    (+8.9 pct) 
  Operating          1.01            2.25           1.48       682 mln   
                                                (+46.5 pct)  (+51.1 pct) 
  Recurring          1.34            2.16           1.44       662 mln   
                                                (+6.9 pct)    (+3.0 pct) 
  Net
  Net              735 mln           1.50         800 mln      365 mln   
                                                (+8.8 pct)   (+18.8 pct) 
  EPS             52.33 yen      107.12 yen      56.99 yen    26.00 yen  
  EPS Diluted     52.08 yen      106.30 yen                              
  Ann Div         30.00 yen       27.50 yen      25.00 yen               
  -Q2 Div         15.00 yen       12.50 yen      12.50 yen               
  -Q4 Div         15.00 yen       15.00 yen      12.50 yen               
  
  NOTE - AFC-HD Ams Life Science Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T

Recent news on AFC-HD AMS Life Science

See all news